Navigation Links
Top Ten Pharma Company Deploys MedNet Solutions' Investigator Initiated Trial Management System

MINNETONKA, Minn., March 19 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, today announced that one of the world's largest pharmaceutical companies has deployed MedNet's Investigator Initiated Trial (IIT) Management System. This system provides a powerful, flexible and efficient solution to manage the entire IIT lifecycle... from proposal to publication... helping to ensure comprehensive, standardized and auditable IIT submissions, decisions and tracking on a world-wide basis.

"We are extremely pleased that MedNet has been selected to deliver the vital technology infrastructure required to fully automate, centralize and streamline the international IIT management processes of this industry leading pharmaceutical organization," stated John M. (Rob) Robertson, President and CEO of MedNet Solutions. "We believe this selection validates MedNet's continued commitment to providing the high level of expertise, technology and support needed to help life sciences organizations achieve operational efficiencies in all aspects of clinical research."

The MedNet IIT Management System delivers robust, highly configurable capabilities that allow pharmaceutical, medical device and biotechnology companies to achieve global IIT management standardization, increased IIT visibility, and reduced IIT program related time and cost expenditures. The solution also delivers the tools needed to shorten timelines from concept submission to publication, minimize redundant studies, and enhance investigator and management satisfaction.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology, and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based solutions that support our customers' clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, and biotechnology organizations on projects spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end. For more information, please visit

    Contact Information:
    Dirk H. Nelson
    Marketing Manager
    601 Carlson Parkway, Suite 605
    Minnetonka, MN  55305
    (763) 258-2735

SOURCE MedNet Solutions
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
2. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
3. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
4. Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures and Supporting the Economy
5. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
6. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
7. Dr. Paul Korner Promoted to Senior Vice President of Ferring International PharmaScience Center U.S.
8. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
9. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
10. Helix BioPharma Announces Q2 2009 Financial Results
11. RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma
Post Your Comments:
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... PHILADELPIA, PA (PRWEB) , ... November 24, 2015 , ... ... young entrepreneurs at competitive events in five states to develop and pitch their BIG ... student projects from each state are competing for votes to win the title of ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th until 19 th ... from 17 th until 19 th November 2015.   ... the first combined scanner in the world which scans both ... two different scanners were required: one for passports and one ... same surface. This innovation is an ideal solution for electronic ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
Breaking Biology News(10 mins):